Shenzhen Salubris Pharmaceuticals Co.,Ltd.’s Net Profit Dropped 11.4% in First Three Quarters of 2023

Shenzhen Salubris Pharmaceuticals Co.,Ltd. (深圳信立泰药业股份有限公司) (002294.SZ) reported a net profit of 477.2 million yuan in the first three quarters of 2023, down 11.4% year-on-year.

Meanwhile, the company posted 2.5 billion yuan in revenue, down 3.6% year-on-year.

At the end of the reporting period, it had 9.4 billion yuan in total assets and 1.5 billion yuan in total liabilities, with a liability-to-asset ratio of 15.7%.